(Q33384544)
Statements
1 reference
A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL. (English)
1 reference
Kazuma Ohyashiki
1 reference
Arinobu Tojo
1 reference
Noriko Usui
1 reference
Kensuke Usuki
1 reference
Akio Urabe
1 reference
Yasuhiro Maeda
1 reference
Itsuro Jinnai
1 reference
Miki Nishimura
1 reference
Tatsuya Kawaguchi
1 reference
Hideo Tanaka
1 reference
Koichi Miyamura
1 reference
Yasushi Miyazaki
1 reference
Timothy Hughes
1 reference
Susan Branford
1 reference
Shinichiro Okamoto
1 reference
Jun Ishikawa
1 reference
Masaya Okada
1 reference
Hiromi Tanii
1 reference
Taro Amagasaki
1 reference
Hiroko Natori
1 reference
Tomoki Naoe
1 reference
19 May 2009
1 reference
1 reference
89
1 reference
679-688
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference